Bar
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
AAVantgarde Bio presents positive data for retinitis pigmentosa and Stargardt disease therapies
The company shared results from the AAVB-081 clinical programme and AAVB-039 preclinical programme at ARVO
PHOTON Results and Their Relation to DME Patients in Your Practice
John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.
Retinal microvascular changes in patients with systemic lupus erythematosus: Importance of OCTA
The biomarkers are especially crucial for patients with lupus nephritis
PULSAR Results and Their Relation to nAMD Patients in Your Practice
John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.
Bausch + Lomb's LuxLife IOL receives CE Mark approval
The LuxLife full range of vision intraocular lens is available in a range of cylinders spanning from +0.75D to +6.00D.
Teprotumumab (Tepezza, Amgen) receives marketing authorisation from MHRA
Teprotumumab is the first therapy specifically licensed for the treatment of moderate-to-severe thyroid eye disease in the UK